​

Coya Therapeutics (COYA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

COYA Stock Forecast

Coya Therapeutics (COYA) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $12.00, with a high of $12.00 and a low of $12.00. This represents a 189.86% increase from the last price of $4.14.

$3 $4 $5 $6 $7 $8 $9 $10 $11 $12 High: $12 Avg: $12 Low: $12 Last Closed Price: $4.14

COYA Stock Rating

Coya Therapeutics stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 6 Strong Sell Sell Hold Buy Strong Buy

COYA Price Target Upside V Benchmarks

TypeNameUpside
StockCoya Therapeutics189.86%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$14.50
Last Closing Price$4.14$4.14$4.14
Upside/Downside--250.24%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 26-7---7
Sep, 26-7---7
Aug, 26-6---6
Jul, 26-6---6
Jun, 26-5---5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 05, 2026Roth Capital$12.00$4.87146.41%189.86%
Nov 05, 2025Lake Street$17.00$5.76195.14%310.63%
Sep 16, 2024Raghuram SelvarajuH.C. Wainwright$18.00$6.12194.12%334.78%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 25, 2026H.C. WainwrightBuyBuyhold
Aug 24, 2026H.C. WainwrightBuyBuyhold
Jun 05, 2026Roth CapitalBuyinitialise
Nov 24, 2025H.C. WainwrightBuyBuyhold
Nov 05, 2025Lake StreetBuyBuyhold
Sep 16, 2024H.C. WainwrightBuyinitialise
Jun 12, 2024Rodman & RenshawBuyinitialise
Jun 08, 2023Chardan CapitalBuyBuyhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.79$-0.98$-1.27---
Avg Forecast$-0.87$-1.10$-1.26$-1.30$-0.56$-0.19
High Forecast$-0.31$-1.08$-1.08$-1.29$-0.20$-0.07
Low Forecast$-1.30$-1.11$-1.44$-1.31$-0.83$-0.28
Surprise %-9.20%-10.91%0.79%---

Revenue Forecast

$0 $7M $14M $21M $28M $35M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.00M$3.55M$7.95M---
Avg Forecast$4.05M$3.67M$6.30M$10.00M$15.00M$25.00M
High Forecast$5.57M$3.74M$8.02M$13.75M$20.63M$34.38M
Low Forecast$2.02M$3.59M$4.58M$5.00M$7.50M$12.50M
Surprise %48.20%-3.09%26.12%---

Net Income Forecast

$-25M $-20M $-15M $-10M $-5M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-7.99M$-14.88M$-21.23M---
Avg Forecast$-7.99M$-11.13M$-12.79M$-13.21M$-5.23M$-1.93M
High Forecast$-3.11M$-10.94M$-10.96M$-13.11M$-1.99M$-675.90K
Low Forecast$-13.22M$-11.32M$-14.61M$-13.31M$-8.47M$-2.87M
Surprise %-33.71%66.01%---

COYA Forecast FAQ

Is Coya Therapeutics stock a buy?

Coya Therapeutics stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Coya Therapeutics is a favorable investment for most analysts.

What is Coya Therapeutics's price target?

Coya Therapeutics's price target, set by 6 Wall Street analysts, averages $12 over the next 12 months. The price target range spans from $12 at the low end to $12 at the high end, suggesting a potential 189.86% change from the previous closing price of $4.14.

How does Coya Therapeutics stock forecast compare to its benchmarks?

Coya Therapeutics's stock forecast shows a 189.86% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Coya Therapeutics over the past three months?

  • October 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Coya Therapeutics’s EPS forecast?

Coya Therapeutics's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.3, marking a 2.36% increase from the reported $-1.27 in 2025. Estimates for the following years are $-0.56 in 2027, and $-0.19 in 2028.

What is Coya Therapeutics’s revenue forecast?

Coya Therapeutics's average annual revenue forecast for its fiscal year ending in December 2026 is $10M, reflecting a 25.85% increase from the reported $7.95M in 2025. The forecast for 2027 is $15M, and $25M for 2028.

What is Coya Therapeutics’s net income forecast?

Coya Therapeutics's net income forecast for the fiscal year ending in December 2026 stands at $-13.213M, representing a -37.75% decrease from the reported $-21.226M in 2025. Projections indicate $-5.229M in 2027, and $-1.931M in 2028.